Department of Endocrinology and Metabolism, Health Sciences University, Dışkapı Training and Research Hospital, Ziraat Mah. Şehit Ömer Halisdemir Cad. No: 20, 06130, Ankara, Türkiye.
J Endocrinol Invest. 2023 Sep;46(9):1935-1940. doi: 10.1007/s40618-023-02064-w. Epub 2023 Mar 16.
The levels of serum phosphorus (P) are low or low-normal in primary hyperparathyroidism (PHPT), and there is an inverse relationship between the levels of parathormone (PTH) and P. However, when considering the diagnostic and surgical indication criteria of PHPT, serum P levels are generally ignored. The aim of this study was to retrospectively evaluate the association of serum P levels with the clinical outcomes of PHPT.
A retrospective evaluation was made of the data of 424 consecutive patients (370 females, 54 males) with PHPT who presented at our centre.
The mean age of the study population was 57 ± 11.68 years. The mean P was 2.57 ± 0.53 mg/dl. Asymptomatic disease was determined in 199 (47%) patients. Male patients had significantly lower levels of P. Symptomatic patients and patients with renal stones, vitamin D < 20 µg/l, calcium level ≥ 11.2 mg/dl, 24 h urinary calcium > 400 mg/day, or hypomagnesemia, were seen to have significantly lower levels of P (p < 0.05). Hypophosphatemia (hypoP) was found in 202 of 424 patients (47%), and these patients had a higher rate of symptomatic disease (63% to 44%, p < .0001). Of the 61 (88%) patients with moderate hypoP, 54 (88%) had at least one of the surgical criteria. A statistically significant increase in the incidence of hypoP was determined in symptomatic and male patients. In the patients with hypoP, serum PTH and urine calcium levels were found to be higher, and lumbar T-scores and serum vitamin D levels were lower. The patients with hypoP had higher rates of renal stones and osteoporosis (p < 0.05).
The current study results show that hypoP is associated with a higher risk of osteoporosis and renal stones in PHPT patients. Even if patients are asymptomatic, moderate hypoP may be associated with poor outcomes of PHPT. Therefore, moderate hypoP may be a new criterion for parathyroidectomy, regardless of hypercalcemia level.
甲状旁腺功能亢进症(PHPT)患者的血清磷(P)水平较低或处于正常低值,甲状旁腺激素(PTH)水平与 P 呈负相关。然而,在考虑 PHPT 的诊断和手术适应证标准时,通常会忽略血清 P 水平。本研究旨在回顾性评估血清 P 水平与 PHPT 临床结局的关系。
对在我院就诊的 424 例连续 PHPT 患者(370 名女性,54 名男性)的数据进行回顾性评估。
研究人群的平均年龄为 57±11.68 岁,平均 P 为 2.57±0.53mg/dl。199 例(47%)患者无症状。男性患者的 P 水平显著较低。有症状的患者和患有肾结石、维生素 D<20μg/l、钙水平≥11.2mg/dl、24 小时尿钙>400mg/天或低镁血症的患者,P 水平显著较低(p<0.05)。424 例患者中有 202 例(47%)存在低磷血症(hypoP),这些患者有症状的疾病发生率更高(63%比 44%,p<0.0001)。在 61 例(88%)中度 hypoP 患者中,54 例(88%)至少有一项手术标准。有症状的患者和男性患者的 hypoP 发生率均有统计学显著增加。在 hypoP 患者中,血清 PTH 和尿钙水平较高,腰椎 T 评分和血清维生素 D 水平较低。hypoP 患者肾结石和骨质疏松症的发生率较高(p<0.05)。
本研究结果表明,PHPT 患者的 hypoP 与骨质疏松症和肾结石的风险增加相关。即使患者无症状,中度 hypoP 也可能与 PHPT 的不良结局相关。因此,中度 hypoP 可能是甲状旁腺切除术的新标准,而与高钙血症水平无关。